Hisami Ikeda

7.4k total citations
170 papers, 5.9k citations indexed

About

Hisami Ikeda is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Hisami Ikeda has authored 170 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 45 papers in Immunology and 31 papers in Molecular Biology. Recurrent topics in Hisami Ikeda's work include Blood groups and transfusion (33 papers), Platelet Disorders and Treatments (22 papers) and Blood transfusion and management (21 papers). Hisami Ikeda is often cited by papers focused on Blood groups and transfusion (33 papers), Platelet Disorders and Treatments (22 papers) and Blood transfusion and management (21 papers). Hisami Ikeda collaborates with scholars based in Japan, China and United States. Hisami Ikeda's co-authors include Mitsuhiro Fujihara, Robert H. Lipsky, NN Tandon, GA Jamieson, DE Greenwalt, CF Ockenhouse, Lloyd J. Old, Toshiaki Kato, Shin Sato and Hiroshi Azuma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Circulation.

In The Last Decade

Hisami Ikeda

158 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hisami Ikeda Japan 38 1.8k 1.6k 971 952 781 170 5.9k
Hugues Lortat‐Jacob France 53 3.8k 2.2× 2.1k 1.3× 504 0.5× 373 0.4× 689 0.9× 146 8.1k
Dorothea Zucker‐Franklin United States 47 2.2k 1.3× 1.8k 1.1× 1.5k 1.5× 237 0.2× 403 0.5× 143 6.7k
Dennis Strand Germany 40 2.5k 1.4× 1.7k 1.1× 280 0.3× 526 0.6× 885 1.1× 85 6.3k
Patrice N. Marche France 42 1.9k 1.1× 2.2k 1.4× 183 0.2× 431 0.5× 441 0.6× 227 5.7k
Toni Antalis United States 40 2.5k 1.4× 838 0.5× 876 0.9× 173 0.2× 570 0.7× 91 5.7k
Anita S. Chong United States 54 2.6k 1.5× 3.7k 2.3× 410 0.4× 291 0.3× 699 0.9× 250 9.1k
Anders Sundan Norway 51 3.5k 2.0× 3.0k 1.9× 2.0k 2.0× 518 0.5× 283 0.4× 160 8.2k
Mi‐Hua Tao Taiwan 36 1.8k 1.0× 2.0k 1.3× 160 0.2× 430 0.5× 419 0.5× 117 5.0k
Alan D. Schreiber United States 50 2.7k 1.5× 2.9k 1.8× 1.7k 1.8× 135 0.1× 819 1.0× 140 8.4k
Eithan Galun Israel 57 5.0k 2.9× 3.0k 1.8× 653 0.7× 2.0k 2.1× 1.1k 1.4× 206 12.6k

Countries citing papers authored by Hisami Ikeda

Since Specialization
Citations

This map shows the geographic impact of Hisami Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisami Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisami Ikeda more than expected).

Fields of papers citing papers by Hisami Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisami Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisami Ikeda. The network helps show where Hisami Ikeda may publish in the future.

Co-authorship network of co-authors of Hisami Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Hisami Ikeda. A scholar is included among the top collaborators of Hisami Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisami Ikeda. Hisami Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Yoshiaki, et al.. (2012). PREPARATION OF REPLACED-PLATELET CONCENTRATES AS A TECHNICAL COOPERATION IN HOKKAIDO RED CROSS BLOOD CENTER (RESULT FOR THE LAST FOUR YEARS). Japanese Journal of Transfusion and Cell Therapy. 58(4). 552–554.
2.
Hirayama, Junichi, Mitsuhiro Fujihara, Chihiro Homma, et al.. (2012). EFFECT OF A 72-HOUR INTERRUPTION OF AGITATION ON IN VITRO PROPERTIES OF PLATELETS WASHED WITH M-SOL. Japanese Journal of Transfusion and Cell Therapy. 58(4). 529–532.
3.
Tamura, Satoru, Junichi Hirayama, Mitsuhiro Fujihara, et al.. (2011). QUALITIES OF PLATELET CONCENTRATES WASHED TWICE OR THREE TIMES. Japanese Journal of Transfusion and Cell Therapy. 57(6). 458–464.
4.
Sakata, Hidekatsu, Keiji Matsubayashi, Hiromi Takeda, et al.. (2011). GENOTYPIC SPECIFICITY OF CHEMILUMINESCENT ENZYME IMMUNOASSAY SCREENING FOR HUMAN PARVOVIRUS B19 ANTIGEN IN BLOOD DONORS. Japanese Journal of Transfusion and Cell Therapy. 57(3). 146–152. 2 indexed citations
5.
Ikeda, Hisami, et al.. (2010). FIVE-YEAR EXPERIENCE OF NAT SCREENING FOR HEV IN BLOOD DONORS IN HOKKAIDO, JAPAN. Vox Sanguinis. 99. 72. 1 indexed citations
6.
7.
Tamura, Satoru, Junichi Hirayama, Chihiro Homma, et al.. (2009). TWO METHODS OF PREPARING WASHED AND/OR REPLACED PLATELET CONCENTRATES. Japanese Journal of Transfusion and Cell Therapy. 55(6). 698–704. 5 indexed citations
8.
Nishikawa, K, Ken Nagao, Kenji Watanabe, et al.. (2007). 病院外での心停止後、自発的循環が回復(ROSC)した患者でのアドレナリン濃度と蘇生後症候群との関係. Circulation. 116(16). 435. 1 indexed citations
10.
Takeda, Hiromi, Hidekatsu Sakata, Keiji Matsubayashi, et al.. (2007). A SENSITIVE CHEMILUMINESCENCE ENZYME IMMUNOASSAY FOR DONOR SCREENING OF HUMAN PARVOVIRUS B19 ANTIGEN. Japanese Journal of Transfusion and Cell Therapy. 53(4). 467–472.
11.
Kato, Hidefumi, Shigeru Takamoto, Hisami Ikeda, et al.. (2006). PRESENT STATUS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) USAGE: SURVEY IN JAPAN. Journal of the Japan Society of Blood Transfusion. 52(3). 422–430. 1 indexed citations
12.
Azuma, Hiroshi, et al.. (2004). Cytotoxic Difference of T Cells Expanded with Anti-CD3 Monoclonal Antibody in the Presence and Absence of Anti-CD28 Monoclonal Antibody. Stem Cells and Development. 13(3). 315–322. 8 indexed citations
13.
Shigematsu, Akio, Masakatsu Yonezumi, Kiyotoshi Imai, et al.. (2004). TRANSFUSION-RELATED ACUTE LUNG INJURY CAUSED BY ANTI-HLA ANTIBODY IN A PATIENT WITH MYELODYSPLASTIC SYNDROME AND GASTRIC CANCER. Journal of the Japan Society of Blood Transfusion. 50(5). 720–725.
14.
Yamaguchi, Miki, Fumiya Hirayama, Shinobu Wakamoto, et al.. (2002). Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion. Transfusion. 42(7). 921–927. 52 indexed citations
15.
Azuma, Hiroshi, Miki Yamaguchi, Mitsuhiro Fujihara, et al.. (2002). Functional evaluation of ex vivo expanded cord blood lymphocytes. Experimental Hematology. 30(4). 346–351. 16 indexed citations
16.
Fujihara, Mitsuhiro, Shinobu Wakamoto, Kenji Ikebuchi, Hiroshi Azuma, & Hisami Ikeda. (2002). . Journal of the Japan Society of Blood Transfusion. 47(6). 829–836. 1 indexed citations
17.
Ariga, Tadashi, Tatsuro Kondoh, Koji Yamaguchi, et al.. (2001). Spontaneous In Vivo Reversion of an Inherited Mutation in the Wiskott-Aldrich Syndrome. The Journal of Immunology. 166(8). 5245–5249. 84 indexed citations
18.
Miyazaki, Tôru, et al.. (1992). A new human monoclonal antibody to rhesus blood group E antigen. Useful Typing Reagent for E-positive red cells.. Journal of the Japan Society of Blood Transfusion. 38(3). 446–452. 1 indexed citations
19.
Kato, Toshiaki, et al.. (1990). Evaluation of HI method as an anti-HBc screening test.. Journal of the Japan Society of Blood Transfusion. 36(1). 56–62. 4 indexed citations
20.
Kobayashi, Masaaki, et al.. (1988). In vivo effects of modified hemoglobin as an artificial oxygen carrier.. 17(6). 1690–1695. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026